Kadhim, Z.A.; Sulaiman, G.M.; Al-Shammari, A.M.; Khan, R.A.; Al Rugaie, O.; Mohammed, H.A.
Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy. Molecules 2022, 27, 5757.
https://doi.org/10.3390/molecules27185757
AMA Style
Kadhim ZA, Sulaiman GM, Al-Shammari AM, Khan RA, Al Rugaie O, Mohammed HA.
Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy. Molecules. 2022; 27(18):5757.
https://doi.org/10.3390/molecules27185757
Chicago/Turabian Style
Kadhim, Zahraa A., Ghassan M. Sulaiman, Ahmed M. Al-Shammari, Riaz A. Khan, Osamah Al Rugaie, and Hamdoon A. Mohammed.
2022. "Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy" Molecules 27, no. 18: 5757.
https://doi.org/10.3390/molecules27185757
APA Style
Kadhim, Z. A., Sulaiman, G. M., Al-Shammari, A. M., Khan, R. A., Al Rugaie, O., & Mohammed, H. A.
(2022). Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy. Molecules, 27(18), 5757.
https://doi.org/10.3390/molecules27185757